The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Fiji Kava (FIJ) appoints healthcare wholesale company ANZ Pharma as its exclusive distributor in New Zealand
  • As part of the agreement, ANZ Pharma will launch the Fiji Kava range of capsules and drinking kava in the New Zealand market
  • The products will be stocked through retail channels such as supermarkets, tourism retail outlooks and petrol, route and convenience stops
  • The contract includes a sales performance requirement of $1.1 which, if met, could extend the deal by another three years
  • Shares in Fiji Kava are trading at 1.8 cents at 2:38 pm AEDT

Fiji Kava (FIJ) has appointed healthcare wholesale company ANZ Pharma as its exclusive distributor in New Zealand.

As part of the agreement, ANZ Pharma will launch the Fiji Kava range of capsules and drinking kava in the New Zealand market.

The products will be stocked through retail channels such as supermarkets, tourism retail outlooks and petrol, route and convenience stops.

The contract includes a sales performance requirement of $1.1 which, if met, could extend the deal by another three years.

“Alongside the Australian market, the New Zealand market has seen a big increase in demand for kava products over the last year,” Fiji Kava CEO Anthony Noble said.

“The team has worked hard to find the right partner, and working with a strong company like ANZ Pharma, who have a stable of national and multinational clients including Bondi Sands, Herbs of Gold, Unilever, Red Bull and Reckitt, gives us great confidence to re-enter this important market.”

ANZ Pharma Director Nitin Patel said the partnership was in alignment with the company’s long-term strategic goal of bringing high-quality products at great value to New Zealand consumers.

Shares in Fiji Kava were trading at 1.8 cents at 2:38 pm AEDT.

fij by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX slides as resources and miners lead broad market sell-off

The Australian sharemarket came under renewed pressure on Tuesday 17th Nov, with selling extending across almost every sector as resources and energy

Mayne Pharma agrees to $604m takeover as Gedeon Richter offers 99% premium to shareholders

Mayne Pharma has agreed to a $604 million takeover by Gedeon Richter, offering shareholders $6.40 per…

QEM identifies new antimony-gold targets at historic US tungsten mine

QEM Limited identifies two new antimony-gold exploration targets at its historic Big It Tungsten Project in…

Hot Chili continues to grow La Verde with another big drill result

Hot Chili has obtained further strong drilling results ahead of a maiden MRE for its La…